Manulife (Manufacturers Life Insurance)
ADMS

Manulife (Manufacturers Life Insurance)’s Adamas Pharmaceuticals ADMS Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-14,336
Closed -$54K – 2925
2019
Q4 		$54K Buy
14,336
+490
+4% +$2.35K ﹤0.01% 2845
2019
Q3 		$92K Buy
+13,846
New +$85.5K ﹤0.01% 2841
2018
Q3 		– Sell
-17,503
Closed -$453K – 4082
2018
Q2 		$453K Buy
17,503
+3,930
+29% +$109K ﹤0.01% 2476
2018
Q1 		$324K Buy
13,573
+2,322
+21% +$73.2K ﹤0.01% 2659
2017
Q4 		$381K Sell
11,251
-318
-3% -$8.88K ﹤0.01% 2503
2017
Q3 		$245K Sell
11,569
-508
-4% -$9.31K ﹤0.01% 2811
2017
Q2 		$211K Sell
12,077
-1,482
-11% -$24.5K ﹤0.01% 2967
2017
Q1 		$238K Buy
13,559
+1,989
+17% +$33.9K ﹤0.01% 2704
2016
Q4 		$196K Sell
11,570
-498
-4% -$7.7K ﹤0.01% 2804
2016
Q3 		$198K Sell
12,068
-47,542
-80% -$723K ﹤0.01% 2785
2016
Q2 		$903K Sell
59,610
-3,000
-5% -$49.5K ﹤0.01% 1679
2016
Q1 		$884K Buy
62,610
+27,108
+76% +$457K ﹤0.01% 1676
2015
Q4 		$1.01K Sell
35,502
-14,372
-29% -$242K ﹤0.01% 1624
2015
Q3 		$834 Buy
49,874
+1,953
+4% +$44.4K ﹤0.01% 1703
2015
Q2 		$1.26K Buy
+47,921
New +$932K ﹤0.01% 1565
2014
Q4 		– Sell
-732
Closed -$14 – 4079
2014
Q3 		$14 Buy
+732
New +$12.6K ﹤0.01% 3475

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ADMS Position: Q1 2020 in Review

Manulife (Manufacturers Life Insurance) sold out of Adamas Pharmaceuticals (ADMS) in Q1 2020, closing a stake of 14,336 shares — an estimated $54K sold.

Manulife (Manufacturers Life Insurance) first reported a position in ADMS in Q3 2014 and held it in 16 quarters. The position peaked at $903K in Q2 2016. 73 funds tracked by Wall St. Rank hold ADMS as of Q1 2020.

  • Manulife (Manufacturers Life Insurance) reported no remaining Adamas Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 14,336 Adamas Pharmaceuticals shares in Q1 2020, an estimated $54K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Adamas Pharmaceuticals in Q3 2014 and held it in 16 quarters.
  • Manulife (Manufacturers Life Insurance)'s Adamas Pharmaceuticals position peaked at $903K in Q2 2016.
  • 73 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q1 2020.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2020, filed 15 May 2020.